iShares Genomics Immunology and Healthcare ETF (IDNA) ETF
Expense Ratio: 0.47% | AUM: 146.36M | Issuer: BlackRock iShares
IDNA Daily Price Range
IDNA 52-Week Price Range
IDNA - Real-Time SMART Grade™
A
Strong Buy
Overall SMART Grade
IDNA has a real-time SMART Grade of A (Strong Buy).
Learn More About SMART Grades™IDNA - Profile & Info
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
| Issuer | BlackRock iShares |
| Expense Ratio | 0.47% |
| Assets Under Management (AUM) | 146.36M |
| Underlying Index | NYSE FactSet Global Genomics and Immuno Biopharma Index |
| Asset Class | Equity |
| ETF Category | Health & Biotech ETFs |
| Net Asset Value (NAV) | $39.03 |
| Options? | Yes |
| Total Holdings | 54 |
IDNA - Top Holdings
IDNA - Price/Volume Stats
| Current price | $39.16 |
| Prev. close | $39.13 |
| Day low | $38.86 |
| Day high | $39.42 |
| 52-week high | $41.30 |
| 52-week low | $22.32 |
| Day Volume | 40,915 |
| Avg. volume | 53,659 |
| Dividend yield | 0.83% |
IDNA - Recent Returns
| 1-mo | 3.90% |
| 3-mo | 3.74% |
| 6-mo | 50.17% |
| 1-year | 61.50% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 31.43% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
| 2015 | N/A |
IDNA - Stock Chart
IDNA - Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Free Investing Ideas Newsletter!
Most Popular Articles
Are Covered Call ETFs Worth The Risks? (QYLD)
Sector Rotation Perspective Update (XLF, XLY, XLK, XLB, XLI, XLE, XLU, XLV, XLP, SPY)- CRB Index Points To Rising Commodities Prices; ETF To Buy Now [United States Commodity Index Fund ETV]
Our Exclusive Tools
